Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
04/14/1992 | US5104651 Stabilized hydrophobic protein formulations of g-csf |
04/13/1992 | WO1992007271A1 Mouse monoclonal antibodies |
04/13/1992 | WO1992007081A2 A monoclonal antibody |
04/13/1992 | WO1992006694A1 Antimicrobial hydrogels |
04/13/1992 | CA2092289A1 Antimicrobial hydrogels |
04/12/1992 | CA2052900A1 Physical stability improvement of liquid nutritional products |
04/11/1992 | CA2053005A1 Emulsifier-free emulsion polymers |
04/11/1992 | CA2046211A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections |
04/10/1992 | WO1992005773A1 Phospholipid analogue vesicle with a succinimidyl moiety |
04/10/1992 | CA2093665A1 Phospholipid analogue vesicle |
04/09/1992 | WO1992005774A1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
04/09/1992 | DE4031881A1 Solvent-free oral pharmaceutical prepn. |
04/08/1992 | EP0479600A2 Delivery of agents |
04/08/1992 | EP0479518A1 Compositions for topical application |
04/08/1992 | EP0479121A1 Skin treatment compositions containing beta-phosphatidyl choline derivatives |
04/08/1992 | EP0479066A2 Methods of preparing stable injectable soluble forms of beta-carotene |
04/08/1992 | EP0479005A1 Gel composition in a dispenser |
04/08/1992 | EP0478906A2 Intra-sorption agent |
04/08/1992 | EP0478838A1 Compositions containing ibuprofen and S-(+)-ibuprofen, and process to prepare them |
04/08/1992 | EP0478732A1 Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
04/08/1992 | EP0478677A1 Novel cyclodextrin inclusion complexes |
04/08/1992 | EP0478665A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
04/08/1992 | EP0204737B1 Preparations for the intramuscular injection of drugs, vitamins or vaccines |
04/07/1992 | US5102665 Pharmaceutical compositions |
04/07/1992 | US5102652 Biodegradable coated paramagnetic colloids and mannitol; storage stability; treating anemia |
04/07/1992 | CA1298557C Compositions comprising 1-substituted azacyclo-alkanes |
04/05/1992 | WO1992005763A1 Composition containing steroid derivatives |
04/05/1992 | WO1992005748A1 Soluble hirudin conjugates |
04/05/1992 | CA2093349A1 Composition containing steroid derivatives |
04/05/1992 | CA2092540A1 Soluble hirudin conjugates |
04/03/1992 | WO1992005866A2 Efficient microcapsule preparation and method of use |
04/03/1992 | CA2092551A1 Efficient microcapsule preparation and method of use |
04/03/1992 | CA2051978A1 The preparation of stable injectable .beta.-carotene solubilizates |
04/02/1992 | WO1992005229A1 Aqueous emulsion and aerosol delivery system using same |
04/02/1992 | WO1992005200A1 Xenobiotic-antibody conjugates |
04/02/1992 | WO1992005197A1 Purification of cytokeratin fragments |
04/02/1992 | WO1992004917A1 Steroids included in cyclodextrines |
04/02/1992 | WO1992004916A2 Particulate agents |
04/02/1992 | WO1992004902A1 Biodegradable gel |
04/02/1992 | WO1992004893A1 Non-aqueous liquid oral suspensions |
04/02/1992 | WO1992004888A1 Preparation of lipophile: hydroxypropyl cyclodextrin complexes by a method using co-solubilizers |
04/02/1992 | WO1992004887A1 Induction of cytotoxic t cell |
04/02/1992 | WO1992004886A1 Fat emulsion for intravenous injection |
04/02/1992 | WO1992002257A3 Renal-selective angiotensin ii antagonists for treatment of hypertension |
04/02/1992 | WO1992002212A3 Use of interfacially-polymerized membranes in delivery devices |
04/02/1992 | DE4131276A1 New metoclopramide salt compsns. with no additives - for use in treatment of vomiting, nausea and in regulation of gastrointestinal motility |
04/02/1992 | DE4030341A1 Treatment of lip cold sores caused by herpes virus - by local application of PVP-iodine |
04/01/1992 | EP0478456A1 Antifungal composition in dry aerosol form |
04/01/1992 | EP0478366A2 Recombinant hybrid immunoglobulin molecules and method of use |
04/01/1992 | EP0477943A1 Topical powder composition containing cyclic AMP derivative |
04/01/1992 | EP0477931A1 Novel adriamycin derivatives |
04/01/1992 | EP0477927A1 Sebaceous excitosecretory agent |
04/01/1992 | EP0477508A1 Improved oligosaccharide conjugate vaccines |
04/01/1992 | EP0477289A1 Anhydrous oil-based liquid suspension for delivering a medicament |
04/01/1992 | EP0477209A1 A preparation for the treatment of fungal infections. |
04/01/1992 | EP0464135A4 Method for reducing side effects of a drug |
04/01/1992 | EP0314689B1 A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase |
04/01/1992 | CN1059845A 润滑剂组合物及其用途 The lubricant composition and use thereof |
03/31/1992 | US5100992 Polyurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
03/31/1992 | US5100669 Polylactic acid type microspheres containing physiologically active substance and process for preparing the same |
03/31/1992 | US5100668 Controlled release systems containing heparin and growth factors |
03/31/1992 | US5100651 Health product, in particular for the caring of the teeth of dogs |
03/31/1992 | US5100378 Enhancement of target cell localization of lymphoid cells |
03/31/1992 | US5099834 Method for anesthesia |
03/31/1992 | CA1298290C Solution ibuprofen complexes, compositions and processes for preparing the same |
03/31/1992 | CA1298288C Cephalosporin salts and injectable compositions |
03/31/1992 | CA1298202C Extraocular methods of treating the eye with liquid perfluorocarbons |
03/31/1992 | CA1298199C Spray dried acetaminophen |
03/31/1992 | CA1298198C Composition comprising l-dopa |
03/29/1992 | WO1992005771A1 Lipid formulation system |
03/29/1992 | CA2052193A1 Topical powder composition containing cyclic amp derivative |
03/28/1992 | WO1992005804A1 Chelating agents |
03/28/1992 | CA2092434A1 Chelating agents |
03/28/1992 | CA2052283A1 Recombinant hybrid immunoglobulin molecules and method of use |
03/27/1992 | CA2052231A1 Sebaceous excitosecretory agent |
03/26/1992 | WO1992005250A1 Prolonging expression of polynucleotides introduced into a cell |
03/26/1992 | CA2092319A1 Prolonging expression of polynucleotides introduced into a cell |
03/25/1992 | EP0477143A2 Pharmaceutical composition having a cicatrising effect |
03/25/1992 | EP0477107A1 Steroids contained in cyclodextrins |
03/25/1992 | EP0476953A2 Viral targeted destruction of neoplastic cells |
03/25/1992 | EP0476777A1 An ophthalmic preparation comprising a povidone-iodine solution |
03/25/1992 | EP0476696A1 A superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
03/25/1992 | EP0476408A1 Chemical conjugation of morpholino anthracyclines to antibodies |
03/25/1992 | EP0476205A1 Sustained release morphine preparation for rectal administration |
03/25/1992 | EP0476156A1 Solid oral preparation containing catechol compound |
03/25/1992 | EP0476045A1 Bioerodible polymers for drug delivery in bone. |
03/25/1992 | EP0476011A1 Photosensitizing diels-alder porphyrin derivatives |
03/25/1992 | CN1015986B Process for preparing bighly pure cyslic esters |
03/24/1992 | US5099012 Antiischemic agents |
03/24/1992 | US5098907 Nonionic surfactants |
03/24/1992 | US5098893 Storage of materials |
03/24/1992 | US5098717 Ethanol, water, a gelling agent, an antihistamine and an antiprurtic agent |
03/24/1992 | US5098692 Gadolium complexes with N6-carboxymethyl-N3,N9-bis(methyl carbamoyl-methyl)-3,6,9-triazaundecanedioic acid and complexes with calcium |
03/24/1992 | US5098606 Lipids, sugars, water and nonionic surfactants for drugs |
03/24/1992 | CA1297791C Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
03/24/1992 | CA1297725C Directly compressible powered maltitol and its process of preparation |
03/22/1992 | CA2090231A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
03/22/1992 | CA2030039A1 Sustained release morphine preparation for rectal administration |
03/21/1992 | CA2051721A1 Nasal pharmaceutical composition |
03/20/1992 | WO1992004918A1 Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |